CFML
MRNA icon

COMPASS FINANCIAL MANAGEMENT LLC’s Moderna MRNA Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.64K Buy
+52
New +$2.69K ﹤0.01% 1245

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's MRNA Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Moderna (MRNA) in Q2 2026: 52 shares worth $3.64K. The stake represents ﹤0.01% of the portfolio and ranks #1245 among its holdings.

545 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 52 shares of Moderna worth $3.64K as of Q2 2026.
  • Moderna was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • Moderna made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #1245 holding.
  • 545 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.